In a 50‑year‑old patient with watery diarrhea, negative Clostridioides difficile test, elevated C‑reactive protein, abnormal liver function tests, pancytopenia, and markedly increased ferritin, should I consider secondary hemophagocytic lymphohistiocytosis (HLH)?

Yes, Strongly Consider Secondary Hemophagocytic Lymphohistiocytosis (HLH)

In a 50-year-old patient presenting with watery diarrhea (C. diff negative), elevated CRP, deranged liver function tests, pancytopenia, and raised ferritin, you should have a high index of suspicion for secondary HLH and proceed urgently with diagnostic workup and empiric treatment if criteria are met.

Why This Constellation Suggests HLH

Your patient's presentation hits multiple cardinal features of secondary HLH:

• Pancytopenia (bi- or trilineage cytopenias are hallmark features) 1
• Hyperferritinemia (particularly if >5,000-10,000 ng/mL) 2
• Deranged liver function tests (elevated transaminases, bilirubin common) 3
• Elevated inflammatory markers (raised CRP fits the hyperinflammatory state) 2
• Gastrointestinal symptoms (diarrhea can be a presenting feature) 4, 5

The combination of marked hyperferritinemia with cytopenias in the context of fever and organ dysfunction should immediately trigger HLH evaluation 2.

Immediate Diagnostic Workup Required

Proceed urgently with the following tests 3:

Essential laboratory studies:

• Ferritin level (if >10,000 ng/mL, highly suggestive)
• Triglycerides (fasting) and fibrinogen (hypofibrinogenemia expected)
• Soluble IL-2 receptor alpha (sCD25) - elevated levels support diagnosis 3
• Complete coagulation panel (PT, aPTT, D-dimer)
• Lactate dehydrogenase (typically elevated)

Infectious workup:

• Blood, urine, and stool cultures
• Viral titers and PCR: EBV, CMV, adenovirus (EBV is most common trigger) 3, 5
• Consider parasitic infections if travel history present 6

Bone marrow examination:

• Aspirate and biopsy looking for hemophagocytosis
• Critical: Also screens for underlying malignancy (lymphoma is major trigger in adults) 7, 8

Additional imaging:

• Chest X-ray, consider CT chest/abdomen/pelvis to evaluate for lymphadenopathy or occult malignancy 7, 8

Calculate the HScore

Use the HScore calculator to assess probability 8, 9:

• HScore >169: 93% probability of HLH
• HScore >220: >99% probability of HLH

Key HScore components your patient likely has: fever, hepatomegaly/splenomegaly, cytopenias, hyperferritinemia, elevated transaminases, hypofibrinogenemia, hypertriglyceridemia.

Critical Diagnostic Pitfall

Do not wait for bone marrow confirmation of hemophagocytosis to initiate treatment if clinical suspicion is high 2. Hemophagocytosis may be absent early or in up to 50% of cases initially 10. The syndrome is rapidly progressive and carries high mortality if untreated.

When to Initiate Empiric Treatment

Start treatment immediately if 2:

• Ferritin >5,000 ng/mL with cytopenias in context of fever, PLUS
• Grade ≥3 organ toxicity (severe transaminitis, renal dysfunction, pulmonary edema), OR
• Patient is clinically deteriorating despite supportive care

Initial Management Strategy

First-line therapy 2, 3, 2:

1. High-dose corticosteroids: Dexamethasone 10 mg/m² IV daily or methylprednisolone 1-2 mg/kg IV 4, 5
2. Consider adding anakinra (IL-1 receptor antagonist) 100-400 mg daily, especially if tocilizumab-refractory or late-onset presentation 2, 4

Avoid tocilizumab as first-line for HLH (it's for cytokine release syndrome in CAR-T patients, not primary HLH treatment) 2, 3.

If severe/refractory after 48 hours 3, 2:

• Escalate immunosuppression
• Etoposide may be considered (though carries lymphocyte toxicity risk) 2
• Urgent hematology consultation for HLH-2004 protocol consideration

Identify and Treat the Underlying Trigger

This is paramount - HLH is secondary in adults 1:

Infection-triggered (most common):

• Start broad-spectrum antibiotics empirically while cultures pending
• If EBV or CMV positive: targeted antiviral therapy (ganciclovir for CMV) + rituximab for EBV 5
• Even C. diff can rarely trigger HLH 11 - consider retesting or empiric treatment if high suspicion

Malignancy-associated (carries worst prognosis):

• Lymphoma (especially DLBCL) is a major adult trigger 7, 8
• Bone marrow biopsy is essential - may reveal occult hematologic malignancy 8
• If lymphoma confirmed, chemotherapy (R-CHOP) is definitive treatment and often rapidly reverses HLH 8

Autoimmune-triggered:

• Consider adult-onset Still's disease if persistent fever, rash, arthritis 4
• Inflammatory bowel disease can rarely trigger HLH 12

Key Clinical Pearls

• Ferritin:CRP ratio: If ferritin is massively elevated (>10,000) but CRP is relatively low, this suggests interferon-γ-driven (not IL-6-driven) inflammation, more consistent with HLH than sepsis 9

• The diarrhea: While infectious diarrhea workup is appropriate 13, 14, don't let negative C. diff distract you from the bigger picture of systemic hyperinflammation

• Age matters: At 50 years, this is secondary HLH until proven otherwise - search aggressively for triggers, especially malignancy 15, 1

• Mortality is high: Without treatment, secondary HLH in adults carries significant mortality, particularly if malignancy-associated 2, 15

Monitoring Treatment Response

Track these parameters closely 6, 9:

• Serial ferritin and sCD25 levels (should decline with effective treatment)
• Resolution of cytopenias
• Normalization of liver function tests
• Improvement in coagulopathy

Transfer to ICU if hemodynamic instability, respiratory compromise, or neurologic deterioration develops 16.